CTXR logo

Citius Pharmaceuticals (CTXR) Cash From Investing

Annual CFI

-$5.00 M
-$5.00 M-100.00%

September 30, 2024

Summary

Performance

1-Year Change

-100%

3-Year Change

+87.5%

5-Year Change

-100%

15-Year Change

-237995.24%

CTXR Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.7%
CTXR annual cash flow from investing activities is higher than 35.7% of companies in Healthcare sector

High & Low

All-time High

$255.70 K
CTXR annual cash flow from investing activities is currently -2055.42% below its historical high of $255.70 thousand

3-Year Low

-$40.01 M

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
CTXR previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
CTXR next annual earnings announcement has not yet been scheduled

OtherCTXRcash flowmetrics:

Annual CFF

$9.97 M
CTXR annual cash flow from financing activities is $9.97 million

Annual CFO

-$28.20 M
CTXR annual cash flow from operations is -$28.20 million

Annual FCF

-$28.20 M
CTXR annual free cash flow is -$28.20 million

Annual CAPEX

-
CTXR annual capital expenditures value is unknown

Quarterly CFI

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTXR Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$255.70 K
CTXR quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

$0.00
CTXR quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTXR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CTXR next earnings announcement is scheduled for Feb 14, 2025

OtherCTXRcash flowmetrics:

Quarterly CFF

-$3.75 M
CTXR quarterly cash flow from financing activities is -$3.75 million

Quarterly CFO

-$5.91 M
CTXR quarterly cash flow from operations is -$5.91 million

Quarterly FCF

-$5.91 M
CTXR quarterly free cash flow is -$5.91 million

Quarterly CAPEX

-
CTXR quarterly capital expenditures value is unknown

TTM CFI

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTXR TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$255.70 K
CTXR TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$40.01 M
CTXR TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTXR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
CTXR next earnings announcement is scheduled for Feb 14, 2025

OtherCTXRcash flowmetrics:

TTM CFF

$9.97 M
CTXR TTM cash flow from financing activities is $9.97 million

TTM CFO

-$28.20 M
CTXR TTM cash flow from operations is -$28.20 million

TTM FCF

-$28.20 M
CTXR TTM free cash flow is -$28.20 million

TTM CAPEX

-
CTXR TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CTXR Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%--
3 y3 years+87.5%--
5 y5 years-100.0%--

CTXR Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+87.5%
5 y5-year<-9999.0%+87.5%
alltimeall time-2055.4%+87.5%

Citius Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-$5.00 M(<-9900.0%)
-
-
Sep 2023
$0.00(-100.0%)
-
-
Dec 2021
-
$0.00(-100.0%)
-$40.01 M(0.0%)
Sep 2021
-$40.01 M(>+9900.0%)
-$40.00 M(>+9900.0%)
-$40.01 M(>+9900.0%)
Jun 2021
-
-$6900.00(<-9900.0%)
-$6900.00(+283.3%)
Sep 2020
-$1800.00(<-9900.0%)
$0.00(-100.0%)
-$1800.00(0.0%)
Jun 2020
-
-$1800.00(<-9900.0%)
-$1800.00(<-9900.0%)
Sep 2019
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 2018
$0.00(-100.0%)
-
-
Sep 2017
-$2100.00(-100.8%)
-
-
Sep 2016
$255.70 K(>+9900.0%)
$0.00(0.0%)
$255.70 K(0.0%)
Jun 2016
-
$0.00(-100.0%)
$255.70 K(0.0%)
Mar 2016
-
$255.70 K(>+9900.0%)
$255.70 K(>+9900.0%)
DateAnnualQuarterlyTTM
Sep 2015
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
$0.00
$0.00(0.0%)
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
-
$0.00
$0.00

FAQ

  • What is Citius Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals annual CFI year-on-year change?
  • What is the all time high quarterly CFI for Citius Pharmaceuticals?
  • What is the all time high TTM CFI for Citius Pharmaceuticals?

What is Citius Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of CTXR is -$5.00 M

What is the all time high annual CFI for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high annual cash flow from investing activities is $255.70 K

What is Citius Pharmaceuticals annual CFI year-on-year change?

Over the past year, CTXR annual cash flow from investing activities has changed by -$5.00 M (-100.00%)

What is the all time high quarterly CFI for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high quarterly cash flow from investing activities is $255.70 K

What is the all time high TTM CFI for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high TTM cash flow from investing activities is $255.70 K